Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Thursday, September 24, 2015

Farewell Nabsys

›
A bit over a week ago brought news that mapping instrument hopeful Nabsys had ceased operations.  As a veteran of one failed biotech, I have...
5 comments:
Thursday, September 17, 2015

How Do You Differentiate Archea and Bacteria in the First Week of High School Biology???

›
I have a long standing interest in biology education -- I seriously considered it as at least a career to explore -- but now I really have s...
3 comments:
Wednesday, September 09, 2015

Freely & Unrepentantly Confessing to Heresy

›
Keith Bradnam reported a huge influx of traffic for a recent post -- not surprising, since he labeled it NSFW (Not Safe For WorK).  And yes...
1 comment:
Tuesday, September 01, 2015

Ion's S5

›
The Ion Torrent team rolled out a new sequencer line this morning, the S5.  The S5, whose impending release had been tipped on the internet ...
8 comments:
Wednesday, August 26, 2015

The Road to Hell is Paved with Bioinformatics Formats

›
If you really want to raise a bioinformaticist's blood pressure, loudly declare your new tool generates output in brand new data formats...
7 comments:
Monday, August 24, 2015

Do Helix's Numbers Work?

›
A number of efforts in the consumer genomics space have been attempted in the past, with 23andMe appearing to make limited headway and Knome...
6 comments:
Friday, July 10, 2015

Clinical Metagenomics Pipelines: Revisiting & Reflecting

›
When I set out to start this blog nearly over eight years ago, I set myself a number of goals.  One goal was to take some risks -- not crazy...
1 comment:
Thursday, July 02, 2015

Leaky clinical metagenomics pipelines are a very serious issue

›
Update: Some significant issues with the tone of this post are discussed in a follow-up . I am a firm believer that the practice of scienc...
6 comments:
Tuesday, June 30, 2015

June 2015: Busting Out All Over with Genomics Technology

›
This month I again entered the prime of my life, though next year my programming brother points out that next year I (and the first Apollo m...
4 comments:
Monday, June 08, 2015

BGI Unveils a Sequencing Factory to Go

›
When I was in George Church's lab, he submitted a grant proposal (which, alas, was not funded) for a sequencing factory to generate one ...
8 comments:
Tuesday, May 26, 2015

Is Illumina Serious About an Alternate Chemistry for the Rapid Amplicon Market?

›
Back in January, at the end of my post on Illumina's new machine lineup I speculated whether Illumina might see a niche for a lower co...
1 comment:
Wednesday, May 20, 2015

London Calling Wrap-Up

›
The second, and final, day of Oxford Nanopore's London Calling conference concluded last Friday -- and I'm behind on writing it up. ...
5 comments:
Friday, May 15, 2015

London Calling Day 1: Highlights

›
Oxford Nanopore's London Calling conference kicked off today; I've Storified a large collection of Tweets from it , covering today ...
3 comments:
Wednesday, May 13, 2015

Oxford Nanopore's London Calling: Pre-meeting speculation

›
Oxford Nanopore's London Calling confab starts up in a matter of hours.  Alas, several issues scotched my plans to attend (not only doe...
2 comments:

PacBio's New Sample Prep Plan: Too Late to the Dance?

›
Pacific Biosciences had a string of announcements around its earnings release last week.  Of particular interest is a collaboration with Rai...
3 comments:
Monday, April 27, 2015

Revisiting the RNA Tie Club

›
As mentioned previously, by wonderful luck I now have regular contact with Ash from the Curious Wavefunction , and he has stimulated a new b...
2 comments:
Monday, April 13, 2015

Interested in the History of Biotech Companies? Don't start with Wikipedia.

›
I'm generally a big fan of Wikipedia and use it often for background research.  I've gotten more active this year in editing it, par...
2 comments:
Tuesday, March 31, 2015

To Properly Assess Cancer Genomics, One Cannot Dismiss It

›
Through a happy series of professional events, I now get to have lunch very regularly with the author of the excellent blog The Curious Wave...
8 comments:
Tuesday, March 10, 2015

A Dovetail Route to Scaffolded Genomes

›
10X Genomics had a lot of buzz at AGBT over their approach to acquiring long range information for complex genomes via a microfluidic-assi...
4 comments:
Monday, March 09, 2015

An Impending Shakeout In Library Prep?

›
My ABGT teleconference-based pieces all had a theme of library preparation.  Library prep has never been as flashy as instrument performan...
‹
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.